- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02721810
Patient Engagement Initiative (PEI)
May 16, 2019 updated by: Johns Hopkins University
Engaging Surrogates and Physicians to Ensure Concordant Critical Care
A no-cost intervention may improve adherence with a recommendation for higher-quality, lower-cost care for patients with critical illness endorsed by a collaborative of critical care societies.
The investigators propose prompting consideration of functional outcomes.
This trial will help establish the impact of the intervention on practice patterns including proxy engagement and elements of shared decision-making.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
116
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Licensed physicians
- At least 4 weeks of clinical work in an I.C.U. in the U.S.A. during the past 12 months
Exclusion Criteria:
- <25 years old
- Non-English speaking
- Primarily practicing medicine outside the U.S.A.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Prompts standard to rounds or electronic medical records.
|
|
|
Experimental: Prompting Intervention
Prompting consideration of 3-month functional outcome.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Presence of acceptable treatment option as assessed by a checklist completed by clinical colleges.
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Level of conflict with proxy with a previously validated single question
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Level of shared decision-making measured using CollaboRATE scale
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Prevalence of communication skills for involving ICU proxies in treatment decisions assessed by a checklist completed by clinical colleges
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Medical interactions assessed using the Roter Interaction Analysis System (RIAS)
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Prevalence of the discussed option of stopping life support as assessed by blinded assessors
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Prevalence of conveying prognosis as assessed by blinded assessors
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Level of shared decision-making measured using CollaboRATE scale as assessed by blinded assessors
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
The Observer OPTIONS5 measure completed by blinded assessors
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
|
Consulting services requested by study participants
Time Frame: 0 to 5 minutes after prompting an intervention
|
0 to 5 minutes after prompting an intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Alison E Turnbull, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Abshire MA, Li X, Basyal PS, Teply ML, Singh AL, Hayes MM, Turnbull AE. Actor feedback and rigorous monitoring: Essential quality assurance tools for testing behavioral interventions with simulation. PLoS One. 2020 May 29;15(5):e0233538. doi: 10.1371/journal.pone.0233538. eCollection 2020.
- Turnbull AE, Hayes MM, Brower RG, Colantuoni E, Basyal PS, White DB, Curtis JR, Needham DM. Effect of Documenting Prognosis on the Information Provided to ICU Proxies: A Randomized Trial. Crit Care Med. 2019 Jun;47(6):757-764. doi: 10.1097/CCM.0000000000003731.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Actual)
February 1, 2018
Study Completion (Actual)
March 19, 2019
Study Registration Dates
First Submitted
March 23, 2016
First Submitted That Met QC Criteria
March 23, 2016
First Posted (Estimate)
March 29, 2016
Study Record Updates
Last Update Posted (Actual)
May 20, 2019
Last Update Submitted That Met QC Criteria
May 16, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00082272
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Istanbul Medeniyet UniversityRecruiting
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
Clinical Trials on Consideration of 3-month functional prognosis
-
Hospices Civils de LyonCompleted
-
Assistance Publique - Hôpitaux de ParisANRS, Emerging Infectious DiseasesNot yet recruitingPost-acute COVID-19 SyndromeFrance
-
NovartisTerminatedHypertensionUnited States, Denmark, Finland, Norway, Sweden
-
McGill University Health Centre/Research Institute...Centre hospitalier de l'Université de Montréal (CHUM)RecruitingInfluenza | COVID 19 | Inflammatory Bowel Disease | Immunocompromised Host | Rheumatoid Arthritis (RA) | Solid Organ Transplant Recipients | Systemic Lupus Erthematosus | People Living With HIVCanada
-
Hospices Civils de LyonCompletedType 2 Diabetes MellitusFrance
-
North-Western State Medical University named after...CompletedEdentulous | Teeth Replacement | Bounded Edentulous Space
-
Takeshi MorimotoCompletedNeoplasms | Venous Thrombosis | AnticoagulantJapan
-
Xiamen Innovax Biotech Co., LtdJiangsu Province Centers for Disease Control and PreventionCompleted
-
Central Hospital, Nancy, FranceCompletedHypertension, Pulmonary | Copd | HyperdistentionFrance
-
Fondazione Don Carlo Gnocchi OnlusCompletedMalnutrition | RehabilitationItaly